“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]
Phase III controlled trials are considered the ‘gold standard’ for assessing vaccine efficacy and safety in humans. These are the trials upon which authorities have assured the public that COVID-19 vaccines are “safe and effective.” The benefits of the vaccines in reducing disease severity and hospitalizations are well-known, but what do we know about the adverse events?Data on adverse events is vital for effective decision-making by regulators, policy makers, doctors, and patients.
On Dec. 8, 2021, the White House’s chief medical advisor, Anthony Fauci, MD, suggested he believed it was likely the U.S. government would change the definition of what it meant to be “fully vaccinated” to include booster shots, as well as the original two-shot regimen of the Pfizer/BioNTech and Moderna/NIAID COVID-19 biologics or one shot […]
According to the U.S. Centers for Disease Control and Prevention (CDC), the federal government of the United States is providing COVID-19 vaccines free of charge to everyone five years and older living in the United States, regardless of their immigration or health insurance status.1 Although the CDC states that COVID vaccines are provided to the […]
A former testing site researcher in Texas has alleged that Pfizer’s pre-licensure BNT162b2 (also known as “Comirnaty”) COVID-19 biologic trials included falsification of data, unblinding patients, employing inadequately trained vaccinators, and delays in following up on experimental COVID vaccine adverse reaction reports.1 According to clinical trial researcher Brook Jackson, the incidences occurred during the phase […]
A 26-year-old man in Dunedin, New Zealand died on Nov. 17, 2021 unexpectedly, 12 days after getting the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) biologic for COVID-19. Rory James Nairn was vaccinated on Nov. 5 and reportedly began to feel heart palpations or “flutters” a few hours after […]
Based on concerns over a growing number of reports of a blood clotting disorder known as thrombosis with thrombocytopenia syndrome (TTS) following vaccination with Johnson & Johnson/Janssen’s experimental human adenovirus vectored Ad26.COV2.S vaccine, the Advisory Committee on Immunization Practices (ACIP) voted 15-0 on Dec. 16, 2021 to recommend the experimental messenger RNA (mRNA) COVID-19 biologics […]
On Dec. 1, 2021, the first case of the new SARS-CoV-2 variant known as Omicron (initially designated “B.1.1.529”) in the United States was confirmed by the U.S. Centers for Disease Control and Prevention (CDC) in California. The case involves a fully vaccinated individual in San Francisco who had returned from a trip to South Africa […]
In an interview with CNBC on Dec. 8, 2021, Pfizer CEO Albert Bourla said that he expects sooner rather than later all Americans will have to get a fourth dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 to try to protect against the Omicron variant of the SARS-CoV-2 virus causing mostly mild COVID disease. […]
On Oct. 29, 2021 the U.S Food and Drug Administration (FDA) approved the use of Pfizer/BioNTech COVID-19 vaccine by five- to 11-year-old children under federal Emergency Use Authorization (EUA) guidelines. As California became the first state to announce that COVID vaccine will be required for children to attend school, districts in several other states plan […]